用AI把医生的口头描述自动转成定制足弓垫,3分钟出可生产模型。
A Research Prototype for Closed-Loop Generative Design of Customized Foot Orthoses via Semantic-Physics Alignment

- 用文本嵌入对齐几何结构,让医生语言直接生成3D足垫设计。
- 模型预测足底压力误差仅0.42毫米,峰值压力降低34.7%。
- 适合想快速试制个性化足部矫形器的团队或研究者使用。
将非结构化临床处方转化为患者专用足弓垫(FOs)受限于语义与物理间的错位:高层次临床意图无法确定性映射到足垫的3D几何参数,现有设计流程仍依赖人工经验且缺乏即时生物力学验证。本文提出TANS-FO,一个研究原型——模块化闭环反馈计算设计流程,用于定制化足弓垫的自动化生成,非临床验证治疗设备。文本对齐神经代理(TANS)利用交叉注意力将临床文本嵌入投影至连续体密度场;图神经网络(GNN)代理实时预测足底应力,替代有限元分析(FEA)。框架基于开源PicoFoot-5K人体测量数据库(5,230名受试者;30+解剖参数)。在标准准静态加载下,GNN代理与Abaqus参考求解器一致(R² = 0.94),整个流程可在数分钟内生成可制造的晶格鞋垫。在18-40岁男性群体中,系统相较参数化CAD实现34.7%的峰值压力降低,贴合误差为0.42毫米。另有一项探索性可行性观察(n=12;2周随访;无对照组)显示疼痛评分从VAS 6.4降至2.1,但此数据仅为初步观察性证据,不构成疗效证明。
原文摘要 · Abstract (English)
Translating unstructured clinical prescriptions into patient-specific foot orthoses (FOs) is hindered by a semantic-physical misalignment: high-level clinical intent is not mapped deterministically onto the 3D geometric parameters of the orthosis, and existing design workflows remain dependent on manual expertise with no instantaneous biomechanical validation. We present TANS-FO, a research prototype-a modular pipeline with closed-loop feedback for computational design automation of customized FOs, not a clinically validated therapeutic device. A Text-Aligned Neural Surrogate (TANS) uses cross-attention to project clinical-text embeddings onto a continuous lattice-density field, while a Graph Neural Network (GNN) surrogate predicts plantar stress in real time as a substitute for Finite Element Analysis (FEA). The framework is anchored on the open-access PicoFoot-5K anthropometric database (5,230 subjects; 30+ anatomical parameters). Under standardized quasi-static loading, the GNN surrogate agrees with an Abaqus reference solver (R^2 = 0.94), and the full pipeline synthesizes manufacturing-ready lattice insoles within minutes. On the Male 18-40 cohort, the proposed system attains a surrogate-predicted peak-pressure reduction of 34.7% over parametric CAD, with a fit error of 0.42 mm. Separately, an exploratory feasibility observation (n = 12; 2-week follow-up; no control group) using VAS pain reporting indicates short-term comfort improvement (VAS 6.4 -> 2.1), but this data is explicitly classified as preliminary observational evidence only-not evidence of clinical efficacy.
Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。